Aldeyra Therapeutics Historical PE Ratio image   This ALDX PE ratio history page last updated 4/23/2024
Aldeyra Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/7/2024
3.85-0.08-0.32NA
Q3 2023
11/3/2023
2.21-0.14-0.56NA
Q2 2023
8/3/2023
7.92-0.15-0.60NA
Q1 2023
5/4/2023
10.39-0.27-1.08NA
Q4 2022
3/9/2023
7.90-0.22-0.88NA
Q3 2022
11/10/2022
5.50-0.25-1.00NA
Q2 2022
8/5/2022
6.92-0.30-1.20NA
Q1 2022
5/5/2022
2.78-0.29-1.16NA
Q4 2021
3/17/2022
4.86-0.27-1.08NA
Q3 2021
10/28/2021
9.00-0.27-1.08NA
Q2 2021
8/5/2021
9.57-0.28-1.12NA
Q1 2021
5/6/2021
12.05-0.25-1.00NA
Q4 2020
3/11/2021
12.07-0.30-1.20NA
Q3 2020
11/5/2020
6.95-0.23-0.92NA
Q2 2020
8/6/2020
6.76-0.25-1.00NA
Q1 2020
5/7/2020
2.83-0.34-1.36NA
Q4 2019
3/12/2020
2.42-0.47-1.88NA
Q3 2019
11/7/2019
5.76-0.69-2.76NA
Q2 2019
8/8/2019
5.40-0.49-1.96NA
Q1 2019
5/9/2019
8.03-0.33-1.32NA
Q4 2018
3/8/2019
7.53-0.39-1.56NA
Q3 2018
11/14/2018
8.93-0.52-2.08NA
Q2 2018
8/9/2018
7.45-0.46-1.84NA
Q1 2018
5/15/2018
8.45-0.43-1.72NA
Q4 2017
3/29/2018
7.50-0.36-1.44NA
Q3 2017
11/9/2017
5.70-0.32-1.28NA
Q2 2017
8/8/2017
4.45-0.35-1.40NA
Q1 2017
5/15/2017
4.15-0.37-1.48NA
Q4 2016
3/30/2017
5.05-0.37-1.48NA
Q3 2016
11/14/2016
6.85-0.38-1.52NA
Q2 2016
8/10/2016
5.82-0.41-1.64NA
Q1 2016
5/9/2016
6.20-0.51-2.04NA
Q4 2015
3/30/2016
4.05-0.46-1.84NA
Q3 2015
11/12/2015
7.26-0.35-1.40NA
Q2 2015
8/11/2015
8.34-0.27-1.08NA
Q1 2015
5/13/2015
7.49-0.32-1.28NA
Q4 2014
3/19/2015
10.60-0.20-0.80NA
Q3 2014
11/10/2014
7.91-0.36-1.44NA
Q2 2014
8/4/2014
3.341.566.240.5
Q1 2014
6/11/2014
6.51-0.04-0.16NA
Aldeyra Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/7/2024
3.85-0.08-0.22NA
Q3 2023
11/3/2023
2.21-0.14-0.56NA
Q2 2023
8/3/2023
7.92-0.15-0.89NA
Q1 2023
5/4/2023
10.39-0.27-1.04NA
Q4 2022
3/9/2023
7.90-0.22-1.06NA
Q3 2022
11/10/2022
5.50-0.25-1.11NA
Q2 2022
8/5/2022
6.92-0.30-1.13NA
Q1 2022
5/5/2022
2.78-0.29-1.11NA
Q4 2021
3/17/2022
4.86-0.27-1.07NA
Q3 2021
10/28/2021
9.00-0.27-1.10NA
Q2 2021
8/5/2021
9.57-0.28-1.06NA
Q1 2021
5/6/2021
12.05-0.25-1.03NA
Q4 2020
3/11/2021
12.07-0.30-1.12NA
Q3 2020
11/5/2020
6.95-0.23-1.29NA
Q2 2020
8/6/2020
6.76-0.25-1.75NA
Q1 2020
5/7/2020
2.83-0.34-1.99NA
Q4 2019
3/12/2020
2.42-0.47-1.98NA
Q3 2019
11/7/2019
5.76-0.69-1.90NA
Q2 2019
8/8/2019
5.40-0.49-1.73NA
Q1 2019
5/9/2019
8.03-0.33-1.70NA
Q4 2018
3/8/2019
7.53-0.39-1.80NA
Q3 2018
11/14/2018
8.93-0.52-1.77NA
Q2 2018
8/9/2018
7.45-0.46-1.57NA
Q1 2018
5/15/2018
8.45-0.43-1.46NA
Q4 2017
3/29/2018
7.50-0.36-1.40NA
Q3 2017
11/9/2017
5.70-0.32-1.41NA
Q2 2017
8/8/2017
4.45-0.35-1.47NA
Q1 2017
5/15/2017
4.15-0.37-1.53NA
Q4 2016
3/30/2017
5.05-0.37-1.67NA
Q3 2016
11/14/2016
6.85-0.38-1.76NA
Q2 2016
8/10/2016
5.82-0.41-1.73NA
Q1 2016
5/9/2016
6.20-0.51-1.59NA
Q4 2015
3/30/2016
4.05-0.46-1.40NA
Q3 2015
11/12/2015
7.26-0.35-1.14NA
Q2 2015
8/11/2015
8.34-0.27-1.15NA
Q1 2015
5/13/2015
7.49-0.320.6811.0
Q4 2014
3/19/2015
10.60-0.200.9611.0
Q3 2014
11/10/2014
7.91-0.36NANA
Q2 2014
8/4/2014
3.341.56NANA
Q1 2014
6/11/2014
6.51-0.04NANA
Quotes delayed 20 minutes

Email EnvelopeFree ALDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aldeyra Therapeutics (ALDX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ALEC PE Ratio History
ALGN PE Ratio History
ALGS PE Ratio History
ALHC PE Ratio History
ALIM PE Ratio History
ALKS PE Ratio History
ALLK PE Ratio History
ALLO PE Ratio History
ALNA PE Ratio History
ALNY PE Ratio History
How should the ALDX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Aldeyra Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ALDX Historical PE Ratio page.

What is the average historical PE for ALDX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ALDX historical PE ratio using the annualized quarterly earnings method works out to 0.5.

What is the average historical PE for ALDX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ALDX historical PE ratio using the TTM earnings method works out to 11.0.

On this page we presented the Aldeyra Therapeutics Historical PE Ratio information for Aldeyra Therapeutics' stock. The average ALDX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ALDX historical PE based on this TTM earnings result method is 11.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ALDX historical PE result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for ALDX had been 3.93, and the most recent quarterly earnings result, annualized, was 6.24. Meanwhile, the most recent TTM earnings summed to 0.68. From these numbers, we calculate the recent ALDX PE on 4/22/2024 based on annualized quarterly EPS was 0.6. Based on ALDX's history, that recent PE is elevated relative to the historical average, with the recent PE 20.0% higher than the historical average PE across our data set for Aldeyra Therapeutics. Looking at the recent ALDX PE on 4/22/2024 based on TTM EPS, we calculate the ratio at 5.8. Based on ALDX's history, that recent PE is low relative to the historical average, with the recent PE 47.3% lower than the average PE across our Aldeyra Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ALDX or any other given stock, valuation analysis for ALDX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Aldeyra Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ALDX. Thanks for visiting, and the next time you need to research ALDX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: GKNT Historical Stock Prices, Institutional Holders of AZZC, Vulcan Materials shares outstanding history.

 

Aldeyra Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.